Company profile
OraSure Technologies, Inc.
NASDAQ: OSUR · Healthcare · Medical - Instruments & Supplies
#335 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
67BFH 60DQ 90GM 32SS 83
v0.1 · 65/100 weight · provisional
↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$113.0M
Rev growth YoY (TTM)
-30.1%
Net income (FY)
-$68.7M
Employees
500
as of 2026-08-13
Market cap
$258.2M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$115.0M$115.0M2025
Net income-$68.7M-$68.7M2025
Operating income-$72.0M-$72.0M2025
Total assets$403.2M$403.2M2025
Liabilities$62.3M$62.3M2025
Equity$340.8M$340.8M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product And Services95%
Other Revenues5%
By geography
UNITED STATES68%
Africa21%
Europe6%
Other Foreign Countries5%
The read
What is OraSure Technologies, Inc.’s revenue?
OraSure Technologies, Inc. booked $115.0M in FY2025 revenue, contracting 38% year over year — slower than 78% of Healthcare companies we track, at a -59.8% net margin.
Peers · Healthcare
Outset Medical, Inc.52DNortech Systems Incorporated71BGyre Therapeutics, Inc.72BAgenus Inc.67BImmunityBio, Inc.58CAnika Therapeutics, Inc.74BNeighbors
Northampton →Key facts
CEOCarrie Eglinton Manner
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBethlehem, PA
ExchangeNASDAQ: OSUR
Employees500
IPO date1986-11-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.